ValueScreener

AbbVie Inc. (ABBV): return on equity, 10 filed years

ROE at AbbVie Inc. was 128.7% in FY2024, the newest year it could be computed. Across the 7 computed years from FY2016 it ranged from 35.3% (FY2020) to 128.7% (FY2024), with a median of 74.9%.

Tonight's figure on the company page: n/a, recomputed 2026-11-06. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.

Year by year

AbbVie Inc.: ROE for each filed fiscal year, with the filing behind each.
Fiscal yearROERead from
FY2016128.4%10-K, filed 2017-02-17
FY2017104.2%10-K, filed 2018-02-16
FY2018

Filed shareholders equity is zero or below, so a return on it is not a measurement (n/m).

n/m10-K, filed 2019-02-27
FY2019

Filed shareholders equity is zero or below, so a return on it is not a measurement (n/m).

n/m10-K, filed 2020-02-21
FY202035.3%10-K, filed 2021-02-19
FY202174.9%10-K, filed 2022-02-18
FY202268.6%10-K, filed 2023-02-17
FY202346.9%10-K, filed 2024-02-20
FY2024128.7%10-K, filed 2025-02-14
FY2025

Filed shareholders equity is zero or below, so a return on it is not a measurement (n/m).

n/m10-K, filed 2026-02-20

How each year is computed

Net income / shareholders equity x 100

Each year is a ratio of lines in that year's filed annual report, with the nightly recompute's own rules for what counts as a filed line. Nothing is estimated, smoothed or filled in: a year that cannot be computed says why.

Read further

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Once a week, what changed in the filings of US-listed companies, and what it can mean for a thesis.